Biological activities of bovine glycomacropeptide

British Journal of Nutrition

Volumn 84, Issue SUPPL. 1, 2000, Pages

  Brody, E P ^a  

^a MS0050   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; GLYCOPROTEIN;

BACTERIAL GROWTH; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; CATTLE; ESCHERICHIA COLI; IMMUNOMODULATION; INHIBITION KINETICS; MOLECULAR BIOLOGY; NONHUMAN; NUTRITIONAL VALUE; PROTECTION; PROTEIN BINDING; PROTEIN STRUCTURE; REVIEW; STOMACH SECRETION; VIBRIO CHOLERAE; VIRUS CELL INTERACTION;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BOS TAURUS; BOVINAE; ESCHERICHIA COLI; UNIDENTIFIED BACTERIOPHAGE; VIBRIO CHOLERAE;

EID: 0034490342     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0007114500002233     Document Type: Review

References (105)

1. Study of the mechanism of acid secretion inhibition with κ-casein peptides in the stomach
2. Bifidius growth-promoting activity of a glycomacropeptide derived from human κ-casein
3. Production of kappa-caseino-glycomacropeptide
4. Effect of gastric digestive products from casein on CCK release by intestinal cells in rat
5. Effect of caseinomacropeptide (CMP) on cholecystokinin (CCK) release in rat
6. Isolation of a glycopolypeptide fraction with Lactobacillus subspecies pennsylvanicus growth-promoting activity from whole human milk casein
7. Physiological activity of products of limited κ-casein proteolysis
8. The benefits of CMP
9. Comparative study of methods for the isolation and purification of bovine κ-casein and its hydrolysis by chymosin
10. Heterogeneity of reduced bovine κ-casein
11. Attachment sites of carbohydrate portions to peptide chain of κ-casein from bovine colostrum
12. Process for the Production of Kappa-casein Glycomacropeptide
13. Infection protectant
14. Nomenclature of proteins of cow's milk: Fifth revision
15. Method for treating a lactic raw material containing GMP
16. Production of kappa-casein macropeptide
17. Extraction of glycoproteins and sialic acid from whey
18. Barrier effect of Bifidobacterium longum on a pathogenic Escherichia coli strain by gut colonization in the germ-free rat
19. The amino-acid and carbohydrate sequences of a short glycopeptide isolated from bovine κ-casein
20. Caseins of various origins and biologically active casein peptides and oligosaccharides: Structural and physiological aspects
21. Localization of the prosthetic sugar groups of bovine colostrum κ-casein
22. Cow κ-casein: Structure of the carbohydrate portion
23. The sugar part of κ-caseins from cow milk and colostrum and its microheterogeneity
24. Interaction of Mycoplasma gallisepticum with sialyl glycoproteins
25. Effect of caseinomacropeptide (CMP) on gastric secretion and plasma levels of digestive hormones in preruminant calves
26. Effect of caseinomacropeptide (CMP) on gastric secretion and plasma gut regulatory peptides in preruminant calves
27. Undialyzable growth factors for Lactobacillus bifidus var pennsylvanicus
28. Bifidus factor II. Its occurence of in milk from different species and in other natural products
29. Bifidus factor. 1. A variant of Lactobacillus bifidus requiring a special growth factor
30. Separation of major casein fractions using cation-exchange fast protein liquid chromatography
31. Actions of cholera toxin and the prevention and treatment of cholera
32. Growth-promoting effects of N-actylneuraminic acid-containing substances on Bifidobacteria
33. Sialylated compounds in human milk and their physiological significance in infants
34. Use of compounds containing or binding sialic acid to neutralize bacterial toxins
35. Studies on the primary structure of cow κ-casein - Structural features of para-κ-casein; N-terminal sequence of κ-caseino-glycopeptide studied with a sequencer
36. Comparative study of cow and sheep κ-caseinoglycopeptides: Determination of the N-terminal sequences with a sequencer and location of the sugars
37. Attachment sites of carbohydrate moieties to peptide chain of bovine κ-casein from normal milk
38. Process of producing κ-casein glycomacropeptides
39. Process for producing κ-casein glycomacropeptides
40. Inhibition by κ-casein glycomacropeptide and lactoferrin of influenza virus hemaglutination
41. Inhibition by lactoferrin and κ-casein glycomacropeptide of binding of cholera toxin to its receptor
42. pH-dependent molecular weight changes of κ-casein glycomacropeptide and its preparation by ultrafiltration
43. Neutralizing agent for an endotoxin comprising a fraction containing κ-casein glycomacropeptide (GMP) as an active ingredient
44. Growth response of Bifidobacterium bifidum to a hydrolytic product isolated from bovine casein
45. Health-enhancing whey proteins
46. The chemistry of gangliosides: A review
47. Identification of N-acetylneuraminyl α2-3 poly-N-acteyl lactosamine glycans as the receptors of sialic acid-binding Streptococcus suis strains
48. Erythrocyte receptors for Mycoplasma pneumoniae are silaylated oligosaccharides of Ii antigen type
49. An improved method for the isolation of κ-casein
50. Casein macropeptide from whey - A new product opportunity
51. Reversed phase high-performance liquid chromatographic separation of bovine kappa-casein macropeptide and characterization of isolated fractions
52. Effect of bovine κ-caseinoglycopeptide on secretion of interleukin-1 family cytokines by P388D1 cells, a line derived from mouse monocyte/macrophage
53. Fractionation and characterization of glycomacropeptide from caseinate and skim milk hydrolyzates
54. Gel chromatography of glycomacropeptide (GMP) from sweet whey on Sephacryl S-200 at different pHs and on Sephadex G-75 in 6M guanidine hydrochloride
55. Anti-plaque and anticaries agent
56. Anti-plaque and anticaries agent
57. Screening for complex carbohydrates inhibiting hemaggluatinations by CFA/I- and CFA/II-expressing enterotoxigenic Escherichia coli strains
58. Specific and nonspecific inhibition of adhesion of oral actinomyces and streptococci to erythrocytes and polystrene by caseinoglycopeptide derivatives
59. A 23 kda membrane glycoprotein bearing NeuNac2-3Gal β1-3GalNAc O-linked carbohydrate chains acts as a receptor for Streptococcus sanguis OMZ 9 on human buccal epithelial cells
60. In vitro modulation of oral bacterial adhesion to saliva-coated hydroxyapatite beads by milk casein derivatives
61. Method for production of a kappa-casein glycomacropeptide and use of a kappa-casein glycomacropeptide
62. Adhesins as lectins: Specificity and role in infection
63. Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer's patch cells by bovine milk caseins and their digests
64. Suppression of interleukin-2 receptor expression on mouse CD4 + T cells by bovine κ-caseinoglycopeptide
65. Inhibition of proliferative responses of mouse spleen lymphocytes by bovine milk κ-casein digests
66. Induction of an interleuken-1 receptor antagonist-like component produced from mouse speen cells by bovine κ-caseinoglycopeptide
67. Bovine κ-casein as inhibitor of the proliferation of mouse splenocytes induced by lipopolysaccharide stimulation
68. Inhibition of mitogen-induced proliferative responses of lymphocytes by bovine κ-caseinoglycopeptides having different carbohydrate chains
69. Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli
70. Response of Bifidobacterium species to growth promoters in human and cow milk
71. Growth-enhancing supplements for various species of the genus Bifidobacterium
72. Bovine milk κ-casein trypsin digest is a growth enhancer for the genus Bifidobacterium
73. Effect of casein hydrolysates on the growth of Bifidobacteria
74. Variations and distributions of O-glycosidically linked sugar chains in bovine κ-casein
75. The chemical structure of a tetrasaccaride containing N-acetylglucosamine obtained from bovine colostrum κ-casein
76. A new isolation method of caseinoglycopeptide from sweet cheese whey
77. Binding of Vibrio cholora toxin and the heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and nonlipid oligosaccharide polyvalent ligands
78. Incorporation of caseinoglycomacropeptide and caseinophosphopeptide into the salivary pellicle inhibits adherence of mutans streptococci
79. Characteristics of macropeptide fractions isolated from whole casein and purified κ-casein
80. An improved method to measure glycomacropeptides (GMP) in renneted milk
81. Process for manufacturing sialic acids-containing composition
82. Pharmaceutical oligosaccharides
83. Evaluation of a porous silica-based ion-exchange medium for the production of protein fractions from rennet- and acid-whey
84. Human normal B lymphocyte accelerating agent
85. Stabilizer for food manufacturing
86. On the physiological activity of κ-casein glycomacropeptide
87. Formation of a peptide inhibitor of gastric secretion from rat milk proteins in vivo
88. Effects of κ-casein glycomacropeptide motility in dogs
89. Dietary proteins as the source of new health promoting bio-active peptides with special attention to glutamine peptide
90. Binding and hemagglutinating properties of the B Subunit(s) of heat-labile enterotoxin isolated from human enterotoxigenic Escherichia coli
91. Process for producing κ-casein glycomacropeptide
92. Casein. IX. Carbohydrate moeity of κ-casein
93. A 360-MHz 1H-NMR study of three oligosaccharides isolated from cow κ-casein
94. Cholera toxin: Interaction of subunits with ganglioside GM1
95. A rapid and sensitive high-performance liquid chromatography method of following the action of chymosin in milk
96. Kinetics of the chymosin-catalyzed proteolysis of κ-casein in milk
97. Inhibitory action of glycomacropeptide produced on the gastric secretion by various humoral stimulants
98. Proteins in milk
99. Detection of cholera-toxin-binding activity of glycomacropeptide from bovine κ-casein and optimization of its production by use of response surface methodology
100. Preparation of κ-casein by gel filtration
101. Growth simulation agent for bifidus and lactobacillus
102. Glycomacropeptide from cheese whey protein concentrate enhances IgA production by lipopolysaccharide-stimulated spleen cells
103. Effects of caseinomacropeptide (CMP) on digestion regulation
104. Fluoride free dental remineralization
105. S-casein and κ-casein